KZKai Zeng

Kai Zeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kai Zeng has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Guodong Li

    Department of General Surgery The Fourth Affiliated Hospital of Harbin Medical University Harbin China

    1 shared publication
  • Jiufeng Wei

    Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China; Bio-Bank of Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China

    1 shared publication
  • Ming Liu

    Department of General Surgery, The Fourth-Affiliated Hospital of Harbin Medical University Harbin, China

    1 shared publication
  • Shuwei Dang

    Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China; Bio-Bank of Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China

    1 shared publication
  • Yuhui Zhou

    Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China; Bio-Bank of Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China

    1 shared publication

Latest Publications

  • Open Access

    Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

    by Jiufeng Wei, Guodong Li, Shuwei Dang, Yuhui Zhou, Kai Zeng, Ming Liu

    Colorectal carcinoma (CRC) is one of the most prevalent malignant tumors worldwide. Screening and early diagnosis are critical for the clinical management of this disease. DNA methylation changes have been regarded as promising biomarkers for CRC diagnosis. Here, we map DNA methylation profiling on CRC in six CRCs and paired normal samples using a 450 K bead array. Further analysis confirms the methylation status of candidates in two data sets from the Gene Expression Omnibus. Receiver operating characteristic (ROC) curves are calculated to determine the diagnostic performances. We identify 1549 differentially methylated regions (DMRs) showing differences in methylation between CRC and normal tissue. Two genes (ADD2andAKR1B1), related to the DMRs, are selected for further validation. ROC curves show that the areas under the curves ofADD2andAKR1B1are higher than that ofSEPT9, which has been clinically used as a screening biomarker of CRC. Our data suggests that aberrant DNA methylation ofADD2andAKR1B1could be potential screening markers of CRC.